|
The Astellas Group's principal business is the research, development, manufacturing and marketing of pharmaceutical products. In the pharmaceutical business, the company conducts research, development and sales in Japan, and supplies raw materials and a portion of products to the company's consolidated subsidiaries in each region. Overseas, Astellas US LLC (U.S.A.) is responsible for headquarters functions in the Americas under Astellas US Holding Inc (U.S.A.). Astellas Pharma US, Inc. (US) and other companies will market the product. Astellas US Technologies Inc. (U.S.A.) is responsible for the technology integration function in the Americas and Astellas Pharma Technologies Inc. (U.S.A.) is responsible for manufacturing; Astellas Pharma Europe Ltd. (U.K.) is responsible for the headquarters function under Astellas B.V. (Netherlands) in EMEA (Europe, Middle East and Africa); and Astellas Pharma Europe Ltd. Astellas Pharma (China) will manufacture and market the product in Asia and Oceania. Astellas Pharma Korea and Astellas Pharma Taiwan Ltd. will sell the product. The company will also engage in research and development of pharmaceuticals using regenerative medicine technology in the field of ophthalmology through a subsidiary. |